The DOI matches its Crossref record.
High-Grade Extremity Soft Tissue Sarcomas: Factors Predictive of Local Recurrence and its Effect on Morbidity and Mortality
Open accessAbstract
OBJECTIVE: To identify patient characteristics associated with the development of local recurrence and the effect of local recurrence on subsequent morbidity and mortality in patients with intermediate- to high-grade extremity soft tissue sarcomas. SUMMARY BACKGROUND DATA: Numerous studies on extremity soft tissue sarcomas have consistently shown that presentation with locally recurrent disease is associated with the development of subsequent local recurrences and that large tumor size and high histologic grade are significant factors associated with decreased survival. However, the effect of local recurrence on patient survival remains unclear. METHODS: From 1975 to 1997, 753 patients with intermediate- to high-grade extremity soft tissue sarcomas were treated at UCLA. Treatment outcomes and patient characteristics were analyzed to identify factors associated with both local recurrence and survival. RESULTS: Patients with locally recurrent disease were at a significantly increased risk of developing a subsequent local recurrence. Local recurrence was a morbid event requiring amputation in 38% of the cases. The development of a local recurrence was the most significant factor associated with decreased survival. Once a patient developed a local recurrence, he or she was about three times more likely to die of disease compared to similar patients who had not developed a local recurrence. CONCLUSIONS: Local recurrence in patients with intermediate- to high-grade extremity soft tissue sarcomas is associated with the development of subsequent local recurrences, a morbid event decreasing functional outcomes and the most significant factor associated with decreased survival. Although 85% to 90% of patients with high-grade extremity soft tissue sarcomas are treatable with a limb salvage approach, patients who develop a local recurrence need aggressive treatment and should be considered for trials of adjuvant systemic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Gamboa, A. C., Gronchi, A., & Cardona, K. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21605 · Cited by 524
Lessons Learned From the Study of 10,000 Patients With Soft Tissue Sarcoma
Brennan, M. F., Antonescu, C. R., Moraco, N., & Singer, S. (2014) · Annals of Surgery · doi:10.1097/sla.0000000000000869 · Cited by 484
Gronchi, A., Lo Vullo, S., Colombo, C., Collini, P., Stacchiotti, S., Mariani, L., Fiore, M., & Casali, P. G. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181cf87fa · Cited by 314
Gronchi, A., Casali, P. G., Mariani, L., Miceli, R., Fiore, M., Lo Vullo, S., Bertulli, R., Collini, P., Lozza, L., Olmi, P., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.160 · Cited by 279
DAMMERER, D., VAN BEECK, A., SCHNEEWEISS, V., & SCHWABEGGER, A. (2020) · In Vivo · doi:10.21873/invivo.12140 · Cited by 14
Metadata
- Authors
- Eilber, F. C., Rosen, G., Nelson, S. D., Selch, M., Dorey, F., Eckardt, J., & Eilber, F. R.
- Venue
- Annals of Surgery
- Published
- 2003-02
- Volume
- 237
- Issue
- 2
- Pages
- 218-226
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2083134761
- Cited by
- 233
- References
- 0
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-Grade Extremity Soft Tissue Sarcomas: Factors Predictive of Local Recurrence and its Effect on Morbidity and Mortality. https://app.cochat.ai/papers/10.1097/01.sla.0000048448.56448.70
- The paper
- Eilber, F. C., Rosen, G., Nelson, S. D., Selch, M., Dorey, F., Eckardt, J., & Eilber, F. R. (2003). High-Grade Extremity Soft Tissue Sarcomas: Factors Predictive of Local Recurrence and its Effect on Morbidity and Mortality. Annals of Surgery. https://doi.org/10.1097/01.sla.0000048448.56448.70
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.